These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 36845390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X.
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H, Sheng W, Zhang G, Yang Q, Yao S, Yue Y, Zhang P, Zhu Y, Wang Q, Chen Y, Zeng H, Weng J, Yu F, Yang J.
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.
    Chen Z, Du D, Li J, Zhang W, Shao J.
    Transl Cancer Res; 2024 Mar 31; 13(3):1268-1289. PubMed ID: 38617510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C, Wu S, Lai L, Liu J, Guo Z, Ye Z, Chen X.
    BMC Bioinformatics; 2023 Jan 03; 24(1):4. PubMed ID: 36597032
    [Abstract] [Full Text] [Related]

  • 14. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W, Xiao JH, Zhang JS, Mao BL, Wang PZ, Wang BL.
    Front Oncol; 2023 Jan 03; 13():1153353. PubMed ID: 37056336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D, Lu W, Zhuo Z, Wang Y, Zhang W, Zhang M.
    BMC Med Genomics; 2023 May 05; 16(1):96. PubMed ID: 37143115
    [Abstract] [Full Text] [Related]

  • 17. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M, Zheng H, Xu K, Yuan Q, Aihaiti Y, Cai Y, Xu P.
    Front Immunol; 2022 May 05; 13():919231. PubMed ID: 35967366
    [Abstract] [Full Text] [Related]

  • 18. Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
    Chen Q, Sun T, Wang G, Zhang M, Zhu Y, Shi X, Ding Z.
    Dis Markers; 2022 May 05; 2022():3265212. PubMed ID: 36452343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.